NCT04691544View on ClinicalTrials.gov

Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

May 5, 2021

Primary Completion Date

September 1, 2023

Study Completion Date

December 31, 2026

Conditions
Irritable Bowel Syndrome
Interventions
BIOLOGICAL

Fecal microbiota transplantation (FMT)

Delivered by enema

Trial Locations (1)

Unknown

Ålesund Hospital, Ålesund

All Listed Sponsors
collaborator

Oslo University Hospital

OTHER

collaborator

Sorlandet Hospital HF

OTHER_GOV

collaborator

Haukeland University Hospital

OTHER

collaborator

Alesund Hospital

OTHER

lead

University Hospital of North Norway

OTHER

NCT04691544 - Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter